Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging.
about
Aging and the environment: a research frameworkPathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalitiesNew insights into coupling and uncoupling of cerebral blood flow and metabolism in the brainMRI/MRS in neuroinflammation: methodology and applicationsMetabolic Alterations Associated to Brain Dysfunction in DiabetesBlood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live trackingDiabetes Mellitus and Blood-Brain Barrier Dysfunction: An OverviewThe role of neuroimaging in elucidating delirium pathophysiology.Inflammation and white matter damage in vascular cognitive impairment.Glutamate permeability at the blood-brain barrier in insulinopenic and insulin-resistant rats.Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment.Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker.Endothelial progenitor cells transplantation attenuated blood-brain barrier damage after ischemia in diabetic mice via HIF-1α.Consensus meeting: monosodium glutamate - an update.The development of blood-retinal barrier during the interaction of astrocytes with vascular wall cells.Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyDo stress markers and anesthetic technique predict delirium in the elderly?Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people.The application of MRI for depiction of subtle blood brain barrier disruption in stroke.Pharmacodynamic effects of darifenacin, a muscarinic M selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers.Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus.Alterations in function and expression of ABC transporters at blood-brain barrier under diabetes and the clinical significances.Interactive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adultsAssessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes.Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladderUse of CNS medications and cognitive decline in the aged: a longitudinal population-based studyTopiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice.Comparative effects of glucose- and mannitol-induced osmolar stress on blood-brain barrier function in ovine fetuses and lambsImpact of cigarette smoke extract and hyperglycemic conditions on blood-brain barrier endothelial cells.Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2 diabetesThe greater sensitivity of elderly APOE ε4 carriers to anticholinergic medications is independent of cerebrovascular disease riskGlutathione in cerebral microvascular endothelial biology and pathobiology: implications for brain homeostasis.Activation of AMP-activated protein kinase alleviates high-glucose-induced dysfunction of brain microvascular endothelial cell tight-junction dynamics.Case of a cerebral abscess caused by Porphyromonas gingivalis in a subject with periodontitisContribution of thrombin-reactive brain pericytes to blood-brain barrier dysfunction in an in vivo mouse model of obesity-associated diabetes and an in vitro rat modelGlucose sensing by GABAergic neurons in the mouse nucleus tractus solitarii.Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRIRelationship between white-matter hyperintensities and hematoma volume and growth in patients with intracerebral hemorrhageNeurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease
P2860
Q24815677-0C93918A-CFEB-4BA5-A101-4F80EF366A3EQ26744840-1880FCDB-2883-4A2A-B1AE-FD73A7019B68Q26745457-90666059-C919-4DE8-A11A-85F27E559EE0Q26771930-092791A5-B2EF-4665-A56B-32E477419EF7Q26783376-A0CBE606-E7DA-4FDB-8C89-A19B613CB8B8Q28067855-DFE07AA2-F72A-48FF-BB0F-6093AD678CF9Q28386522-638FC0E8-2FCF-4180-818B-9FFA00F6A289Q31094049-9AD81B1F-012D-496A-9E1C-3F599A9C1294Q33611323-CDBA72DE-060E-4924-9C5B-1CE3BF2880FBQ33618412-ACB46298-C592-444E-8EA3-74CA206431FDQ33631080-3DDFD63C-1F6D-4931-9C2A-1C1B0B88E5D5Q33785359-EAA76AE9-3E65-4647-96AA-D41416C18152Q33893649-B4F11FD6-D6E6-43E5-95E9-252CD3BA2C71Q33999283-A3967214-8429-4684-81F5-23792C61C7EFQ34096257-541BF00E-CA98-4184-9451-835AB97438E8Q34237709-8428C9DD-9879-488D-AD5C-8288B38C3429Q34364100-60313182-8700-45B3-AA9B-E50453CB3D24Q34406773-22ED033C-52F2-4E2C-898F-D1BEE87BB720Q34459884-EB90056A-6F21-45AA-9061-CBB40A128626Q34561743-66D286F1-2877-4EAD-A8D7-9434A4A39D93Q34590922-60A80C03-25F1-47BF-8D33-B165B2CCC012Q34669279-E43C6F22-5256-423D-BBB4-50BF6E7A0F52Q35167347-ADEC3423-C4C7-4DE0-A389-50007F9593C1Q35402503-D658D6F5-2FDE-41FB-BAF9-79E880FA4668Q35408197-BB0F78CB-2F27-4CB2-87EF-366F5AAC3A5CQ35546189-6851FD0B-CD99-4985-AB41-EEF727C49467Q35580037-C272EADB-129F-42E9-B1C5-E589CE3CB7DAQ35646049-5BC3DEBD-F47E-430F-B9C5-3D63B21EEA46Q35883101-79EF1F0B-8E81-4BA6-BECB-A01FA11CD69CQ35884677-219E27BE-0306-4D95-B5DB-DE2337B66597Q35945738-6571B3EF-89E1-4CF4-B7A0-F2F670F3367FQ36007813-869E21B0-2C6D-4716-BF1C-1FCB962BB7ECQ36057680-A3BF16E3-34ED-401D-B074-4060E31215CBQ36218667-60A76E81-6128-45D6-B3B5-9A03BC7716ABQ36287881-900B8512-DB80-416F-B0A6-4096A932E6CCQ36368063-4F4A49A0-26CB-4DDB-A6AA-673899BEC23EQ36496907-A56D17EA-2467-4E87-8E36-8F4C4F02C302Q36501363-FD728D60-3DAB-47A2-8849-9CA71BE79FFFQ36766419-EBCADA09-4098-4C21-ABF8-7174B92AD28FQ36767796-A9E8A1AB-A5FA-4021-819D-85FF342F07BE
P2860
Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Increased blood-brain barrier ...... um magnetic resonance imaging.
@ast
Increased blood-brain barrier ...... um magnetic resonance imaging.
@en
type
label
Increased blood-brain barrier ...... um magnetic resonance imaging.
@ast
Increased blood-brain barrier ...... um magnetic resonance imaging.
@en
prefLabel
Increased blood-brain barrier ...... um magnetic resonance imaging.
@ast
Increased blood-brain barrier ...... um magnetic resonance imaging.
@en
P2093
P2860
P356
P1476
Increased blood-brain barrier ...... um magnetic resonance imaging.
@en
P2093
P2860
P356
10.1136/JNNP.74.1.70
P407
P577
2003-01-01T00:00:00Z